[{"Assets_0_Q2_USD":"15117556000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"30.71","EarningsPerShareBasic_2_Q2_USD":"63.49","EarningsPerShareDiluted_1_Q2_USD":"30.32","EarningsPerShareDiluted_2_Q2_USD":"62.7","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"268234000.0","NetIncomeLoss_1_Q2_USD":"914114000.0","NetIncomeLoss_2_Q2_USD":"1891528000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q2_USD":"715931000.0","RevenuesConverted_2_Q2_USD":"1442727000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q2_USD":"11594880000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"30148000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"30167000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"29764000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"29793000.0","filed":"20210730","footnote":null,"form":"10-Q","fp":"Q2","fy":"2021.0","name":"BIO-RAD LABORATORIES, INC.","period":"20210630","qtrs":"0","uom":"USD"}]